Metraipolis › archive › dc_504379e1dafe
Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience — Europe PMC PMID:41065930
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41065930
- DOI
- 10.1007/s00415-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T10:42:16.669Z
- SHA-256 of the archived text
d53a29f302fb44974a3ecc99724422c96eba221bdeb949ce3b501c9a3c32cb73- Stable URL of this page
https://metraipolis.com/documento/dc_504379e1dafe
How to cite
Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience — Europe PMC PMID:41065930 — Europe PMC (en), https://europepmc.org/article/MED/41065930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_504379e1dafe (Metraipolis archive dc_504379e1dafe, sha256 d53a29f302fb44974a3ecc99724422c96eba221bdeb949ce3b501c9a3c32cb73)
BibTeX
@misc{dc504379e1dafe,
title = {Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience — Europe PMC PMID:41065930},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41065930},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_504379e1dafe; sha256 d53a29f302fb44974a3ecc99724422c96eba221bdeb949ce3b501c9a3c32cb73},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41065930. Agents can read the archived copy with the MCP tool read_document.